Exploring the Barriers to and Facilitators of Using Virtual Reality Relaxation for Patients With Psychiatric Problems: Qualitative Focus Group Study
- PMID: 40497635
- PMCID: PMC12198698
- DOI: 10.2196/65308
Exploring the Barriers to and Facilitators of Using Virtual Reality Relaxation for Patients With Psychiatric Problems: Qualitative Focus Group Study
Abstract
Background: Stress is a key transdiagnostic factor in the onset and recurrence of psychiatric disorders. Virtual reality (VR) in mental health care, particularly virtual natural environments, shows promising results in promoting relaxation, as evidenced by tools such as VRelax. While initial studies have demonstrated the efficacy of VRelax, further implementation in routine mental health care requires a systematic exploration of its use by patients. Understanding these perspectives can help tailor VR tools to meet the needs of users better and enhance their effectiveness in clinical settings.
Objective: This study aims to identify patient-perceived barriers to and facilitators of using VR relaxation as a self-management relaxation tool to support its implementation in mental health care.
Methods: Four focus groups were conducted with 19 participants with a wide range of psychiatric problems, including burnout, attention-deficit/hyperactivity disorder, anxiety disorder, depressive disorder, bipolar disorder, obsessive-compulsive disorder, and posttraumatic stress disorder. Participants were recruited via a network of people with lived experience, health care professionals, and social media. Semistructured interview guides with open-ended questions were used to investigate barriers and facilitators. People with psychiatric problems were instructed to use VRelax at home at least 3 times before the focus group discussions. Thematic analysis was conducted to identify barriers and facilitators.
Results: The focus group discussions generated 7 themes with various subthemes. The sense of autonomy was identified as a facilitator, indicating users' experience of feeling in control and independent, which allowed them to manage and operate VRelax on their own. On the other hand, participants indicated that for optimal long-term use, there should be a balance between autonomy and structured guidance and integration into therapy. Perceived usefulness, ease of use, and immersive factors were identified as both barriers and facilitators. Participants had positive initial experiences with VRelax but also reported that the effects of virtual natural environments might diminish with continued use. Usefulness might vary by the phase of psychiatric problems and the individual's momentary emotional state. Participants saw the plug-and-play design of VRelax as helpful but also indicated the importance of easy navigation within the program, including the ability to quickly find specific natural environments. Three barriers were identified: shortcomings in user guidance; perceived problems in transitioning back to reality; and physical hindrances, such as the discomfort caused by the VR glasses.
Conclusions: For optimal implementation of VR relaxation in mental health care, personalized VR experiences should be facilitated, such as offering a specific selection of virtual natural environments based on the momentary emotional state, while fostering user autonomy. Integration of VR tools into ongoing treatment is important, aligning with shared decision-making principles. In addition, reducing the steps required during the starting and the closing processes is crucial, alongside addressing challenges such as physical discomfort and inadequate instructions.
Keywords: AI; artificial intelligence; barriers and facilitators; implementation; psychiatry; qualitative analysis; qualitative research; relaxation; stress; virtual reality.
©Lisanne M Robbemond, JWH Mathijs Nijland, Manna Alma, Wim Veling, Catheleine MG van Driel. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 11.06.2025.
Conflict of interest statement
Conflicts of Interest: WV is the cofounder and chief scientific officer of VRelax BV, the company that developed VRelax in collaboration with the University Medical Center Groningen and holds shares in VRelax BV. LMR, JWHMN, and CMGvD conducted thematic analyses to avoid conflict of interest implications. All other authors declare no conflicts of interest.
Figures
Similar articles
-
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843. JBI Database System Rev Implement Rep. 2016. PMID: 27532314
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159. Health Soc Care Deliv Res. 2025. PMID: 40548558
-
Factors that impact on the use of mechanical ventilation weaning protocols in critically ill adults and children: a qualitative evidence-synthesis.Cochrane Database Syst Rev. 2016 Oct 4;10(10):CD011812. doi: 10.1002/14651858.CD011812.pub2. Cochrane Database Syst Rev. 2016. PMID: 27699783 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
References
-
- Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association; 2013.
-
- Ten Have M, Tuithof M, van Dorsselaer S, Schouten F, Luik AI, de Graaf R. Prevalence and trends of common mental disorders from 2007-2009 to 2019-2022: results from the Netherlands Mental Health Survey and Incidence Studies (NEMESIS), including comparison of prevalence rates before vs. during the COVID-19 pandemic. World Psychiatry. 2023 Jun;22(2):275–85. doi: 10.1002/wps.21087. https://europepmc.org/abstract/MED/37159351 - DOI - PMC - PubMed
-
- Selye H. The Stress of Life. New York, NY: McGraw-Hill Education; 1956.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
